Drug · DIN 02523906
TEPADINA
Authorized, but not sold for a year or more
Authorized, but the company reports it has not been sold in Canada for at least 12 months.
Status Dormant since July 31, 2026; first marketed June 25, 2025.
- Drug Identification Number (DIN)
- 02523906
- Company (DIN owner)
- Adienne SaLugano, Tessin, Switzerland
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Thiotepa L01AC01
- Class
- Human
- Record last updated
- August 5, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| THIOTEPA | 400 MG | BAG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 30, 2021: NOC 27316Supplement to a New Drug Submission (SNDS) · Nwe strength. new container closure system.convert product monograph to 2020 format. update to package insert and labels
Other DINs named TEPADINA
- DIN 02462680 · Marketed
- DIN 02462702 · Marketed
- DIN 02567059 · Approved